Technical Specifications Compound: Glycyl-L-Histidyl-L-Lysine Copper Complex (GHK-Cu) Format: Lyophilized peptide Strength: 50 mg per vial Purity: 9899% (COA included) Appearance: Blue-hued lyophilized powder Category: Research reagent (non-clinical) Intended Use This product is intended exclusively for: Laboratory research In-vitro experimentation Biochemical and molecular assays Mechanistic pathway studies Preclinical, non-human model exploration Institutional or academic research programs Not intended for: Human or veterinary consumption Cosmetic or dermatological use Injection, ingestion, inhalation, or topical use Medical, therapeutic, or clinical applications This material is not approved by Health Canada, FDA, or any regulatory authority for clinical use
TCEP reduces disulfide bonds and sulfenic acids but not sulfinic or sulfonic acids (Reisz et al , 2013)
Expert-led care: Providers adjust your dose, manage side effects, and tailor treatment to your health history
Dont attempt to switch on your own, especially if youve been customizing your dose or injection schedule
This content should not replace personalized guidance from your healthcare provider
In a Chinese phase II clinical trial, mazdutide decreased HbA1c by 1.41% to 1.67% in a dose-dependent manner, while a placebo decreased HbA1c by + 0.03% [102]